-
Targetable ERBB2 Mutations in Neurofibroma/Schwannoma Hybrid Nerve Sheath Tumors
Study
EGAS00001003776
-
Single cell RNA sequencing of 33 primary colorectal cancer
Study
EGAS00001003779
-
Studying the single cell characteristics of pancreatic cancer
Study
EGAS00001003889
-
Ulcerative colitis study - WES data
Study
EGAS00001003801
-
Integration of intra-sample contextual error modeling for improved detection of somatic mutations
Study
EGAS00001003806
-
Single cell sequencing: Capturing the origin and dynamics of chromosomal copy-number heterogeneity
Study
EGAS00001003812
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET) - Intratumoural immune heterogeneity
Study
EGAS00001003814
-
Preservation of stemness in high-grade serous ovarian cancer organoids requires low Wnt environment
Study
EGAS00001003821
-
The evolutionary steps from primary to metastatic prostate cancer are largely uncharted, and the ability to use DNA present in body fluids as correlates of aggregate metastatic status is under-examined. We reconstructed phylogenies in ten prostate cancer patients with fatal disease using deep targeted sequencing of the prostate, adjacent and distant organs, as well as plasma, serum, and cerebrospinal fluid at various time points. A total of 163 samples are studied.
Study
EGAS00001003848
-
ctDNA to predict risk of progression and death after trifluridin/tipiracil therapy
Study
EGAS00001006883
-
RNA sequencing data of 257 samples from 106 patients with HR+/HER2- breast cancer treated with AC plus paclitaxel or letrozole plus ribociclib (SOLTI-1402 CORALLEEN trial)
Study
EGAS00001007060
-
Evaluation of triple negative breast cancer with heterogeneous immune infiltration
Study
EGAS00001007159
-
Evolution_of_the_cancer_epigenome_in_myeloproliferative_neoplasms_TGS
Study
EGAS00001003863
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Epigenome wide DNA methylation assay of gingivo-buccal oral squamous cell carcinoma using single base resolution high throughput array
Study
EGAS00001003896
-
Cistrome-partitioning reveals convergence of somatic mutations and risk-variants on master transcription regulators in primary prostate tumors
Study
EGAS00001003928
-
RNAseq
Study
EGAS00001007212
-
Mutational signature in colorectal cancer induced by genotoxic pks+ E. coli
Study
EGAS00001003934
-
Developing somatic copy number and mutation calling tools for a bespoke sequencing platform
Study
EGAS00001007195
-
Targeted_sequencing_of_embryonic_variants___Warm_Autopsy
Study
EGAS00001003952
-
Rapid identification of somatic genome rearrangements as personalized biomarkers for blood-based cancer monitoring
Study
EGAS00001003963
-
genome-wide cfDNA methylation analysis
Study
EGAS00001003958
-
RNA-Sequencing data of patient derived normal fibroblasts (NFs), cancer associated fibroblasts (CAFs) and tumor spheroid samples
Study
EGAS00001007205
-
WGS
Study
EGAS00001007211
-
Whole Exome Sequencing data of six chRCC tumors corresponding to three patients
Study
EGAS00001007104
-
SCLC tumor sequencing
Study
EGAS00001003985
-
Whole exome sequencing from early stage non-small cell lung cancer patients at MDACC
Study
EGAS00001004026
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004008
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
Berlin Neuroblastoma Dataset
Study
EGAS00001004022
-
TNBC ctDNA Targeted Panel
Study
EGAS00001006937
-
HGSOC organoid sequencing study
Study
EGAS00001007189
-
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune contexture, clinical outcome and sensitivity to targeted therapies
Study
EGAS00001004612
-
Berlin Neuroblastoma Dataset Update 2021
Study
EGAS00001005604
-
cfDNA dataset from the urine supernatant of ovarian cancer patients and healthy controls
Study
EGAS00001007238
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 1).
Study
EGAS00001002630
-
Digital tEchnology For Lung Cancer Treatment
Study
EGAS00001007219
-
SDH_deficient_renal_tumours___WGS_
Study
EGAS00001004102
-
SDH_deficient_renal_tumours___RNA_
Study
EGAS00001004103
-
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Study
EGAS00001007242
-
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Study
EGAS00001004114
-
Genomic_characterisation_of_MGUS__
Study
EGAS00001004124
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
TransNEO neoadjuvant breast cancer study
Study
EGAS00001004582
-
Dissection of the molecular complexity of colorectal cancer in pre-clinical models identifies predictive signatures of sensitivity to EGFR inhibitors
Study
EGAS00001001752
-
METABRIC: Data from Pereira et al (2016), The somatic mutation profiles of 2433 breast cancers refine their genomic and transcriptomic landscapes. Nat Comms 7.
Study
EGAS00001001753
-
The miR-185/PAK6 Axis Predicts Therapy Response and Regulates Survival of Drug-Resistant Leukemic Stem Cells in Chronic Myeloid Leukemia
Study
EGAS00001004153
-
Inferring expressed genes by whole-genome sequencing of plasma DNA
Study
EGAS00001001754
-
FAM50A_Disruption_in_TOV21G_Cells___RNAseq
Study
EGAS00001004156
-
UCSF Pediatric Bithalamic Glioma Genome Project
Study
EGAS00001004033
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Study
EGAS00001004196
-
Oesophageal_Adenocarcinoma_Organoid_Hi_C
Study
EGAS00001003122
-
X10_sequencing_of_Oesophageal_Adenocarcinoma_Organoids
Study
EGAS00001003264
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
Oesophageal_Adenocarcinoma_Organoid_PacBio
Study
EGAS00001007163
-
Chip_seq_oesophageal_adenocarcinoma_
Study
EGAS00001007180
-
Single Cell RNAseq of blood and tumor from renal cancer patients
Study
EGAS00001004230
-
Whole exome sequencing of chemotherapy-resistant muscle-invasive urothelial bladder cancer
Study
EGAS00001004231
-
Immunoreactive_p53_areas_in_human_skin_2
Study
EGAS00001004463
-
The_Little_Princess_Knowledge_Bank_
Study
EGAS00001004237
-
: Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumours
Study
EGAS00001004239
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Adult granulosa cell tumor WGS data cohort with corresponding reference germline WGS data
Study
EGAS00001004249
-
Organoid_Derivation_Project___GRCh38___RNAseq
Study
EGAS00001004677
-
Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Study
EGAS00001004289
-
MethCORR: DNA Methylation-based Characterization, Classification and Prognostication of Colorectal Cancer using Archival Formalin-fixed, Paraffin-embedded Tissue
Study
EGAS00001004293
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Molecular_risk_stratification_in_patients_with_T1_colorectal_cancer_WES
Study
EGAS00001005734
-
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
Study
EGAS00001007291
-
H021-Master Umbrella study2 (not to be released)
Study
EGAS00001005145
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
Single molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer
Study
EGAS00001007248
-
Subtype specific studies of breast cancer progression. Milan cohort.
Study
EGAS00001004390
-
Degradation of Cyclin K/CDK12 is a druggable vulnerability of colorectal cancer (H012)
Study
EGAS00001004517
-
GBM stem cell lines and PRMT5 inhibitor
Study
EGAS00001004397
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
Clinical outcomes and immune correlates of response to nivolumab plus chemoradiotherapy in women with locally-advanced cervical cancer – NiCOL study
Study
EGAS00001007297
-
RNA-sequencing data from 195 B-cell precursor acute lymphoblastic leukemias and mate pair whole genome sequencing data from 15 B-cell precursor acute lymphoblastic leukemias
Study
EGAS00001001795
-
Cell-free DNA sequencing data of healthy control, atrophic gastritis, and gastric cancer patients’ blood
Study
EGAS00001007308
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Comparing nodal versus bony metastatic spread using tumour phylogenies
Study
EGAS00001001801
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Analysis of Loose Ends in Cancer Genome Structure
Study
EGAS00001007324
-
RNA sequencing data of 66 matched primary and recurrent high grade serous ovarian cancer
Study
EGAS00001002660
-
Molecular analysis of CRC in patients with Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD)
Study
EGAS00001004497
-
Clonal_selection_after_gene_therapy_in_SCD___Duplex_sequencing
Study
EGAS00001007253
-
Whole exome sequencing of Finnish hereditary breast cancer families
Study
EGAS00001001835
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Prospective high-throughput genome profiling in advanced cancers:
Study
EGAS00001004554
-
FGFR-driven urothelial cancer
Study
EGAS00001007335
-
Breast cancer sequencing data
Study
EGAS00001007336
-
Transcriptomic profiling of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Study
EGAS00001004770
-
Somatic mutations in healthy and leukemic blood progenitors reveal evolutionary mechanisms underlying childhood leukemia and differential patient outcome
Study
EGAS00001004593
-
DNA polymerase and mismatch repair deficient cancers exert distinct genome-wide microsatellite signatures 2
Study
EGAS00001004816
-
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
Study
EGAS00001007210